Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


A functional variant at 19q13.3, rs967591G>A, is associated with shorter survival of early-stage lung cancer.

Jeon HS, Jin G, Kang HG, Choi YY, Lee WK, Choi JE, Bae EY, Yoo SS, Lee SY, Lee EB, Kim YT, Lee J, Cha SI, Kim CH, Jheon S, Kim IS, Park JY.

Clin Cancer Res. 2013 Aug 1;19(15):4185-95. doi: 10.1158/1078-0432.CCR-12-2792. Epub 2013 Jun 17.


A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.

Yin J, Vogel U, Ma Y, Wang H, Wang C, Liang D, Yue L, Ma J, Li X.

Lung Cancer. 2012 Jun;76(3):286-91. doi: 10.1016/j.lungcan.2012.01.001. Epub 2012 Feb 14.


Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women.

Yin J, Guo L, Wang C, Wang H, Ma Y, Liu J, Liang D, Ma J, Zhao Y.

Gene. 2013 Jul 25;524(2):228-31. doi: 10.1016/j.gene.2013.04.017. Epub 2013 Apr 24.


Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.

Rafrafi A, Chahed B, Kaabachi S, Kaabachi W, Maalmi H, Hamzaoui K, Sassi FH.

Hum Immunol. 2013 Oct;74(10):1368-74. doi: 10.1016/j.humimm.2013.06.033. Epub 2013 Jul 2.


Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.

Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G, Hu Z, Shen H.

Lung Cancer. 2011 Nov;74(2):164-9. doi: 10.1016/j.lungcan.2011.03.005. Epub 2011 Apr 22.


Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.

Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.

Clin Cancer Res. 2009 Mar 1;15(5):1794-800. doi: 10.1158/1078-0432.CCR-08-1770. Epub 2009 Feb 24.


PPP1R13L variant associated with prognosis for patients with rectal cancer.

Chae YS, Kim JG, Kang BW, Lee SJ, Jeon HS, Park JS, Choi GS, Lee WK.

J Cancer Res Clin Oncol. 2013 Mar;139(3):465-73. doi: 10.1007/s00432-012-1346-4. Epub 2012 Nov 21.


A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.

Wang L, Wang LE, Mao L, Spitz MR, Wei Q.

Clin Cancer Res. 2010 Jul 15;16(14):3779-85. doi: 10.1158/1078-0432.CCR-10-0269. Epub 2010 May 13.


The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.

Vangsted AJ, Klausen TW, Gimsing P, Abildgaard N, Andersen NF, Gregersen H, Nexø BA, Vogel UB.

Ann Hematol. 2011 Jun;90(6):675-84. doi: 10.1007/s00277-010-1105-z. Epub 2010 Nov 3.


Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.

Guo H, Bai Y, Xu P, Hu Z, Liu L, Wang F, Jin G, Wang F, Deng Q, Tu Y, Feng M, Lu D, Shen H, Wu T.

J Clin Oncol. 2010 Apr 10;28(11):1928-35. doi: 10.1200/JCO.2009.24.4954. Epub 2010 Mar 15.


Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer.

Lee EB, Jeon HS, Yoo SS, Choi YY, Kang HG, Cho S, Cha SI, Choi JE, Park TI, Lee BH, Park RW, Kim IS, Kang YM, Kim CH, Jheon S, Jung TH, Park JY.

Ann Surg Oncol. 2010 Oct;17(10):2608-18. doi: 10.1245/s10434-010-1082-4. Epub 2010 Apr 27.


VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.

Heist RS, Zhai R, Liu G, Zhou W, Lin X, Su L, Asomaning K, Lynch TJ, Wain JC, Christiani DC.

J Clin Oncol. 2008 Feb 20;26(6):856-62. doi: 10.1200/JCO.2007.13.5947.


Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.

Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y.

Lung Cancer. 2011 Jul;73(1):32-7. doi: 10.1016/j.lungcan.2010.11.001. Epub 2010 Dec 9.


Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.

Chien WP, Wong RH, Cheng YW, Chen CY, Lee H.

Ann Surg Oncol. 2010 Apr;17(4):1194-202. doi: 10.1245/s10434-009-0853-2. Epub 2009 Nov 26.


Association of the transforming growth factor ß1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.

Togashi Y, Masago K, Fujita S, Kim YH, Sakamori Y, Hatachi Y, Fukuhara A, Nagai H, Mio T, Mishima M.

Oncol Rep. 2011 Feb;25(2):377-82. doi: 10.3892/or.2010.1098. Epub 2010 Dec 10.


A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.

Sung WW, Wang YC, Cheng YW, Lee MC, Yeh KT, Wang L, Wang J, Chen CY, Lee H.

Clin Cancer Res. 2011 Sep 15;17(18):5991-9. doi: 10.1158/1078-0432.CCR-11-0227. Epub 2011 Aug 1.


A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer.

Cheng J, Ha M, Wang Y, Sun J, Chen J, Wang Y, Tong C.

J Cancer Res Clin Oncol. 2012 Feb;138(2):231-8. doi: 10.1007/s00432-011-1090-1. Epub 2011 Nov 20.


Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.

Kim M, Kang HG, Lee SY, Lee HC, Lee EB, Choi YY, Lee WK, Cho S, Jin G, Jheon HS, Son JW, Lee MH, Jung DK, Cha SI, Kim CH, Kang YM, Kam S, Jung TH, Jheon S, Park JY.

Cancer Sci. 2010 Nov;101(11):2436-42. doi: 10.1111/j.1349-7006.2010.01699.x.


Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.

Chen Y, Liu H, Wu W, Li Y, Li J.

J Exp Clin Cancer Res. 2013 Jul 24;32:45. doi: 10.1186/1756-9966-32-45.


AKT1 polymorphisms and survival of early stage non-small cell lung cancer.

Kim MJ, Kang HG, Lee SY, Jeon HS, Lee WK, Park JY, Lee EB, Lee JH, Cha SI, Kim DS, Kim CH, Kam S, Jung TH, Park JY.

J Surg Oncol. 2012 Feb;105(2):167-74. doi: 10.1002/jso.22071. Epub 2011 Aug 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk